Sign In
Buy DGNOF
$0.196
-0.0045 (-2.25%)
At Close: Jul 31, 2026
BROSSARD, Quebec, April 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
DIAGNOS Provides Additional Information on Amendment to Convertible Debentures
03:45pm, Monday, 14'th Apr 2025
BROSSARD, Quebec, April 14, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
DIAGNOS Provides Update on its Health Canada Medical Device Licence Application
06:30am, Wednesday, 09'th Apr 2025
BROSSARD, Quebec, April 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
DIAGNOS Announces Amendment to Convertible Debentures
04:57pm, Monday, 31'st Mar 2025
BROSSARD, Quebec, March 31, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health
DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device
09:15am, Wednesday, 12'th Mar 2025
BROSSARD, Quebec, March 12, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health
DIAGNOS Announces Amendment to Convertible Debentures
02:34pm, Friday, 28'th Feb 2025
BROSSARD, Quebec, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in early detection of critical health is
DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
09:05am, Tuesday, 25'th Feb 2025
BROSSARD, Quebec, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS to Present at Centurion One Capital 8th Annual Toronto Growth Conference
10:37am, Monday, 24'th Feb 2025
Brossard, Quebec--(Newsfile Corp. - February 24, 2025) - Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) ("DIAGNOS" or the "Corporation"), a pioneer in early detection of critical health issues t
Correction - Diagnos Announces Closing of Private Placement
03:30pm, Friday, 14'th Feb 2025
In the original press release dated February 5, 2025, announcing the closing of a private placement of 6,715,370 units issued at a price of $0.30 per unit, for gross proceeds of $2,014,611, the number
DIAGNOS Announces Closing of Private Placement
05:09pm, Wednesday, 05'th Feb 2025
BROSSARD, Quebec, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues thro
DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada
01:46pm, Thursday, 30'th Jan 2025
BROSSARD, Quebec, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS to Present at The Microcap Conference 2025
02:47pm, Tuesday, 28'th Jan 2025
BROSSARD, Quebec, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Announces the Engagement of Promoter
03:30pm, Monday, 13'th Jan 2025
BROSSARD, Quebec, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Announces Closing of Private Placement
03:45pm, Friday, 25'th Oct 2024
BROSSARD, Quebec, Oct. 25, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues thro
DIAGNOS Announces the Engagement of Market Maker Consultant
03:45pm, Thursday, 17'th Oct 2024
BROSSARD, Quebec, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues thro
